Company intelligence / Profile preview

Beijing Biosis Healing Biological Technology

Beijing, Beijing, Chinaen.biosishealing.com ↗

Ownership: Private
Development stage: Commercial

Overview

Biosis Healing has developed a mature SIS biomaterial platform with over ten product lines for soft tissue repair. Products are approved by regulatory agencies including CE mark in Europe, FDA clearance in the US for several staplers and patches as of 2022, and NMPA approval in China. The company claims strong clinical adoption across more than thirty countries. Clinical results are not detailed but products have received positive feedback from surgeons.

Therapeutic areas: GastroenterologyCardiovascularNeurologyOther
Modalities: BiologicImplantable medical device (SIS-based)Surgical instrument
Industry: Implantable Medical Devices

Partnerships

Dingxin Capital (investment partner)Fanghe Capital (investment partner)Galaxy Yuanhui (investment partner)

Beyond the preview

Go deeper on Beijing Biosis Healing Biological Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Biosis Healing Biological Technology.

Explore the full profile